AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT FOR MYELODYSPLASIA AFTER CHEMOTHERAPY FOR POSTTRANSPLANT LYMPHOMA IN A CARDIAC TRANSPLANT RECIPIENT AT 10 YEARS
Authors: LISTER J SIMPSON JK DEMAGALHAESSILVERMAN MM RYBKA WB DONNENBERG AD MYERS DJ BALL ED
Citation: J. Lister et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANT FOR MYELODYSPLASIA AFTER CHEMOTHERAPY FOR POSTTRANSPLANT LYMPHOMA IN A CARDIAC TRANSPLANT RECIPIENT AT 10 YEARS, Bone marrow transplantation, 19(9), 1997, pp. 943-945
RELATIONSHIP OF CD34(-BLOOD STEM-CELL TRANSPLANTATION() CELL DOSE TO EARLY AND LATE HEMATOPOIESIS FOLLOWING AUTOLOGOUS PERIPHERAL)
Authors: KISS JE RYBKA WB WINKELSTEIN A DEMAGALHAESSILVERMAN M LISTER J DANDREA P BALL ED
Citation: Je. Kiss et al., RELATIONSHIP OF CD34(-BLOOD STEM-CELL TRANSPLANTATION() CELL DOSE TO EARLY AND LATE HEMATOPOIESIS FOLLOWING AUTOLOGOUS PERIPHERAL), Bone marrow transplantation, 19(4), 1997, pp. 303-310
HIGH-DOSE CYCLOPHOSPHAMIDE, CARBOPLATIN, AND ETOPOSIDE WITH AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH BREAST-CANCER
Authors: DEMAGALHAESSILVERMAN M RYBKA WB LEMBERSKY B BLOOM EJ LISTER J PINCUS SM VOLOSHIN M WILSON J BALL ED
Citation: M. Demagalhaessilverman et al., HIGH-DOSE CYCLOPHOSPHAMIDE, CARBOPLATIN, AND ETOPOSIDE WITH AUTOLOGOUS STEM-CELL RESCUE IN PATIENTS WITH BREAST-CANCER, American journal of clinical oncology, 19(2), 1996, pp. 169-173
TOXICITY OF BUSULFAN AND CYCLOPHOSPHAMIDE (BU CY2) IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES/
Authors: DEMAGALHAESSILVERMAN M BLOOM EJ DONNENBERG A LISTER J PINCUS S RYBKA WB BALL ED
Citation: M. Demagalhaessilverman et al., TOXICITY OF BUSULFAN AND CYCLOPHOSPHAMIDE (BU CY2) IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES/, Bone marrow transplantation, 17(3), 1996, pp. 329-333
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION USING LARGE-VOLUME LEUKAPHERESIS (LVL) IN NORMAL DONORS
Authors: KISS JE RYBKA WB DANDREA P BALL ED
Citation: Je. Kiss et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION USING LARGE-VOLUME LEUKAPHERESIS (LVL) IN NORMAL DONORS, Transfusion, 36(9), 1996, pp. 105-105
EVALUATION OF A HIGH CD34(-CELL TRANSPLANTATION() CELL DOSE FOR HEMATOPOIETIC STEM)
Authors: RYBKA WB KISS J LISTER J DEMAGALHAESSILVERMAN M BALL ED
Citation: Wb. Rybka et al., EVALUATION OF A HIGH CD34(-CELL TRANSPLANTATION() CELL DOSE FOR HEMATOPOIETIC STEM), Blood, 88(10), 1996, pp. 1596-1596
AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AND ADOPTIVE IMMUNOTHERAPY WITH ACTIVATED NATURAL-KILLER-CELLS IN THE IMMEDIATE POSTTRANSPLANT PERIOD
Authors: LISTER J RYBKA WB DONNENBERG AD DEMAGALHAESSILVERMAN M PINCUS SM BLOOM EJ ELDER EM BALL ED WHITESIDE TL
Citation: J. Lister et al., AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION AND ADOPTIVE IMMUNOTHERAPY WITH ACTIVATED NATURAL-KILLER-CELLS IN THE IMMEDIATE POSTTRANSPLANT PERIOD, Clinical cancer research, 1(6), 1995, pp. 607-614
A UNIQUE POPULATION OF CD34(-BLOOD() CELLS IN CORD)
Authors: NIMGAONKAR MT ROSCOE RA PERSICHETTI J RYBKA WB WINKELSTEIN A BALL ED
Citation: Mt. Nimgaonkar et al., A UNIQUE POPULATION OF CD34(-BLOOD() CELLS IN CORD), Stem cells, 13(2), 1995, pp. 158-166
LATE GRAFT FAILURE DUE TO DUAL BONE-MARROW INFECTION WITH VARIANT-A AND VARIANT-B OF HUMAN HERPESVIRUS-6
Authors: ROSENFELD CS RYBKA WB WEINBAUM D CARRIGAN DR KNOX KK ANDREWS DF SHADDUCK RK
Citation: Cs. Rosenfeld et al., LATE GRAFT FAILURE DUE TO DUAL BONE-MARROW INFECTION WITH VARIANT-A AND VARIANT-B OF HUMAN HERPESVIRUS-6, Experimental hematology, 23(7), 1995, pp. 626-629
REVERSIBLE CYCLOSPORINE-INDUCED CORTICAL BLINDNESS IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS
Authors: MEMON M DEMAGALHAESSILVERMAN M BLOOM EJ LISTER J MYERS DJ PINCUS SM RYBKA WB BALL ED
Citation: M. Memon et al., REVERSIBLE CYCLOSPORINE-INDUCED CORTICAL BLINDNESS IN ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 15(2), 1995, pp. 283-286
AUGMENTATION OF CHIMERISM IN WHOLE-ORGAN RECIPIENTS BY SIMULTANEOUS INFUSION OF DONOR BONE-MARROW CELLS
Authors: RAO AS FONTES P ZEEVI A TRUCCO M DODSON FS RYBKA WB SHAPIRO R JORDAN M PHAM SM RILO HL SESKEY T TODO S SCANTLEBURY V VIVAS C DEMETRIS AJ FUNG JJ STARZL TE
Citation: As. Rao et al., AUGMENTATION OF CHIMERISM IN WHOLE-ORGAN RECIPIENTS BY SIMULTANEOUS INFUSION OF DONOR BONE-MARROW CELLS, Transplantation proceedings, 27(1), 1995, pp. 210-212
HEMATOPOIETIC PROGENITOR-CELL CONTENT OF VERTEBRAL BODY MARROW USED FOR COMBINED SOLID-ORGAN AND BONE-MARROW TRANSPLANTATION
Authors: RYBKA WB FONTES PA RAO AS WINKELSTEIN A RICORDI C BALL ED STARZL TE
Citation: Wb. Rybka et al., HEMATOPOIETIC PROGENITOR-CELL CONTENT OF VERTEBRAL BODY MARROW USED FOR COMBINED SOLID-ORGAN AND BONE-MARROW TRANSPLANTATION, Transplantation, 59(6), 1995, pp. 871-874
LATE HEMATOPOIETIC RECONSTITUTION CORRESPONDS WITH CD34-BLOOD STEM-CELL (PBSC) DOSE INFUSED( PERIPHERAL)
Authors: KISS JE RYBKA WB DANDREA P WINKELSTEIN A BALL ED
Citation: Je. Kiss et al., LATE HEMATOPOIETIC RECONSTITUTION CORRESPONDS WITH CD34-BLOOD STEM-CELL (PBSC) DOSE INFUSED( PERIPHERAL), Transfusion, 35(10), 1995, pp. 144-144
COST-EFFECTIVENESS OF SINGLE-DONOR VS RANDOM DONOR PLATELETS FOR AVOIDING DONOR EXPOSURES IN BONE-MARROW TRANSPLANT RECIPIENTS
Authors: TRIULZI DJ ANDEREGG KA WEISSFELD J KISS JE RYBKA WB
Citation: Dj. Triulzi et al., COST-EFFECTIVENESS OF SINGLE-DONOR VS RANDOM DONOR PLATELETS FOR AVOIDING DONOR EXPOSURES IN BONE-MARROW TRANSPLANT RECIPIENTS, Blood, 86(10), 1995, pp. 423-423
TREATMENT OUTCOMES FOR THE MANAGEMENT OF GRAFT-VS-HOST DISEASE FOLLOWING CYCLOSPORINE AND PREDNISONE PROPHYLAXIS
Authors: RYBKA WB BLOOM E DONNENBERG AD LISTER J PINCUS S SCHWINGHAMMER T DEMAGALHAESSILVERMAN M BALL E
Citation: Wb. Rybka et al., TREATMENT OUTCOMES FOR THE MANAGEMENT OF GRAFT-VS-HOST DISEASE FOLLOWING CYCLOSPORINE AND PREDNISONE PROPHYLAXIS, Blood, 86(10), 1995, pp. 1567-1567
REVERSAL OF GRAFT-VERSUS-HOST DISEASE WITH INFUSION OF AUTOLOGOUS BONE-MARROW
Authors: RICORDI C TZAKIS AG ZEEVI A RYBKA WB DEMETRIS AJ FONTES PAC NALESNIK MA TRUCCO M UKAH FO BALL ED MULLEN EE MARINO IR FUNG JJ STARZL TE
Citation: C. Ricordi et al., REVERSAL OF GRAFT-VERSUS-HOST DISEASE WITH INFUSION OF AUTOLOGOUS BONE-MARROW, Cell transplantation, 3(2), 1994, pp. 187-192
ATG TREATMENT INDUCES AN ABSOLUTE NK LYMPHOCYTOSIS FOLLOWING TRANSPLANTATION WITH LYMPHOCYTE DEPLETED MATCHED UNRELATED MARROW
Authors: DONNENBERG AD DONNENBERG VS NEUDORF S RYBKA WB BALL ED
Citation: Ad. Donnenberg et al., ATG TREATMENT INDUCES AN ABSOLUTE NK LYMPHOCYTOSIS FOLLOWING TRANSPLANTATION WITH LYMPHOCYTE DEPLETED MATCHED UNRELATED MARROW, Experimental hematology, 22(8), 1994, pp. 696-696
PROGENITOR CELLS AND ACCELERATED ENGRAFTMENT IN CHEMOTHERAPY NAIVE PATIENTS FOLLOWING HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: RYBKA WB KISS JE MAGALHAESSILVERMAN M LISTER J LEMBERSKY B ROSCOE R MIERSKI J KEANE J OLIVER J WINKELSTEIN A BALL ED
Citation: Wb. Rybka et al., PROGENITOR CELLS AND ACCELERATED ENGRAFTMENT IN CHEMOTHERAPY NAIVE PATIENTS FOLLOWING HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 777-777
AMPLIFICATION OF THE GRAFT-VERSUS-HOST REACTION BY CYCLOPHOSPHAMIDE -DEPENDENCE ON TIMING OF DRUG ADMINISTRATION
Authors: LEHNERT S RYBKA WB
Citation: S. Lehnert et Wb. Rybka, AMPLIFICATION OF THE GRAFT-VERSUS-HOST REACTION BY CYCLOPHOSPHAMIDE -DEPENDENCE ON TIMING OF DRUG ADMINISTRATION, Bone marrow transplantation, 13(4), 1994, pp. 473-477
ENUMERATION OF CD34-CELLS FOR RECONSTITUTION FOLLOWING MYELOABLATIVE THERAPY( HEMATOPOIETIC STEM)
Authors: ROSCOE RA RYBKA WB WINKELSTEIN A HOUSTON AM KISS JE
Citation: Ra. Roscoe et al., ENUMERATION OF CD34-CELLS FOR RECONSTITUTION FOLLOWING MYELOABLATIVE THERAPY( HEMATOPOIETIC STEM), Cytometry, 16(1), 1994, pp. 74-79
HUMAN-TO-BABOON BONE-MARROW TRANSPLANTATION AFTER CONDITIONING WITH NONLETHAL IRRADIATION
Authors: FONTES P RAO AS RICORDI C ZEEVI A KOCOVA M RYBKA WB UKAH FO MULLEN E VASKO C TRUCCO M DEMETRIS AJ FUNG JJ STARZL TE
Citation: P. Fontes et al., HUMAN-TO-BABOON BONE-MARROW TRANSPLANTATION AFTER CONDITIONING WITH NONLETHAL IRRADIATION, Transplantation proceedings, 26(6), 1994, pp. 3367-3368
COMBINED BONE-MARROW AND WHOLE-ORGAN TRANSPLANTATION FROM THE SAME DONOR
Authors: RAO AS FONTES P ZEEVI A TRUCCO M SHAPIRO R DEMETRIS AJ TZAKIS AG CARROLL PB RUDERT WA DODSON FS RYBKA WB PHAM SM SCANTLEBURY V ROHAL S RICORDI C FUNG JJ STARZL TE
Citation: As. Rao et al., COMBINED BONE-MARROW AND WHOLE-ORGAN TRANSPLANTATION FROM THE SAME DONOR, Transplantation proceedings, 26(6), 1994, pp. 3377-3378
HUMAN BONE-MARROW OBTAINED FROM VERTEBRAL BODIES - CELL ISOLATION, PHENOTYPING, PROGENITOR ASSAY, AND TRANSPLANTATION
Authors: FONTES P RAO AS RICORDI C RYBKA WB DODSON FS BROZNICK B LU L ZEEVI A THOMSON AW VASKO C SESKEY T CARROLL PB FUNG JJ STARZL TE
Citation: P. Fontes et al., HUMAN BONE-MARROW OBTAINED FROM VERTEBRAL BODIES - CELL ISOLATION, PHENOTYPING, PROGENITOR ASSAY, AND TRANSPLANTATION, Transplantation proceedings, 26(6), 1994, pp. 3406-3407
SIMULTANEOUS SOLID-ORGAN, BONE-MARROW, AND ISLET ALLOTRANSPLANTATION IN TYPE-I DIABETIC-PATIENTS
Authors: CARROLL PB FONTES P RAO AS RICORDI C RILO HLR ZEEVI A TRUCCO M SHAPIRO R RYBKA WB SCANTLEBURY V DODSON FS TZAKIS AG RUDERT WA BEHBOO R KARATZAS T KHAN R DEMETRIS AJ FLOHI J FUNG JJ STARZL TE
Citation: Pb. Carroll et al., SIMULTANEOUS SOLID-ORGAN, BONE-MARROW, AND ISLET ALLOTRANSPLANTATION IN TYPE-I DIABETIC-PATIENTS, Transplantation proceedings, 26(6), 1994, pp. 3523-3524
XENOTRANSPLANTATION OF HEMATOPOIETIC-CELLS RESISTANT TO HIV AS A POTENTIAL TREATMENT FOR PATIENTS WITH AIDS
Authors: RICORDI C TZAKIS AG RYBKA WB FONTES P BALL ED TRUCCO M KOCOVA M TRIULZI D MCMICHAEL J DOYLE H GUPTA P FUNG JJ STARZL TE
Citation: C. Ricordi et al., XENOTRANSPLANTATION OF HEMATOPOIETIC-CELLS RESISTANT TO HIV AS A POTENTIAL TREATMENT FOR PATIENTS WITH AIDS, Transplantation proceedings, 26(3), 1994, pp. 1302-1303
Risultati: 1-25 | 26-39